Jubilant Biosys is a global contract research, development, and manufacturing organization supporting pharmaceutical and biotechnology companies across the drug discovery and development lifecycle. With more than two decades of experience and a team of over 2,400 employees across five sites in India, the company provides integrated scientific services to clients worldwide, with additional presence in the United States, Europe, and Japan.
Its capabilities span early-stage drug discovery through development and GMP manufacturing. Discovery services include biology, medicinal chemistry, DMPK, and toxicology, while development and manufacturing capabilities support chemical development, GMP intermediates, active pharmaceutical ingredients, and clinical and commercial supply. Jubilant Biosys has also expanded its platform to include biologics and other complex modalities, including antibody-drug conjugates, monoclonal antibodies, oligonucleotides, and peptides.
The company combines scientific expertise with advanced technologies, including AI and machine learning, to support complex drug discovery and development programs. Jubilant Biosys also incorporates considerations such as process efficiency, environmental impact, supply chain resilience, quality, and ESG into its operations. Through this broad range of capabilities, the company serves as an integrated CRDMO partner for pharmaceutical and biotechnology organizations seeking support from early discovery through manufacturing.
.png)